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The Rho Pathway Mediates Transition to an Alveolar Type I Cell
Phenotype During Static Stretch of Alveolar Type II Cells
Abstract
Stretch is an essential mechanism for lung growth and development. Animal models in which fetal lungs have
been chronically over or underdistended demonstrate a disrupted mix of type II and type I cells, with static
overdistention typically promoting a type I cell phenotype. The Rho GTPase family, key regulators of
cytoskeletal signaling, are known to mediate cellular differentiation in response to stretch in other organs.
Using a well-described model of alveolar epithelial cell differentiation and a validated stretch device, we
investigated the effects of supraphysiologic stretch on human fetal lung alveolar epithelial cell phenotype.
Static stretch applied to epithelial cells suppressed type II cell markers (SP-B and Pepsinogen C, PGC), and
induced type I cell markers (Caveolin-1, Claudin 7 and Plasminogen Activator Inhibitor-1, PAI-1) as
predicted. Static stretch was also associated with Rho A activation. Furthermore, the Rho kinase inhibitor
Y27632 decreased Rho A activation and blunted the stretch-induced changes in alveolar epithelial cell marker
expression. Together these data provide further evidence that mechanical stimulation of the cytoskeleton and
Rho activation are key upstream events in mechanotransduction-associated alveolar epithelial cell
differentiation.
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Abstract
Stretch is an essential mechanism for lung growth and development. Animal models in which fetal
lungs have been chronically over- or under-distended demonstrate a disrupted mix of type II and
type I cells, with static overdistention typically promoting a type I cell phenotype. The Rho
GTPase family, key regulators of cytoskeletal signaling, are known to mediate cellular
differentiation in response to stretch in other organs. Using a well-described model of alveolar
epithelial cell differentiation and a validated stretch device, we investigated the effects of
supraphysiologic stretch on human fetal lung (HFL) alveolar epithelial cell phenotype. Static
stretch applied to epithelial cells suppressed type II cell markers (SP-B and Pepsinogen C, PGC),
and induced type I cell markers (Caveolin-1, Claudin 7 and Plasminogen Activator Inhibitor-1,
PAI-1) as predicted. Static stretch was also associated with Rho A activation. Furthermore, the
Rho kinase (ROCK) inhibitor Y27632 decreased Rho A activation, and blunted the stretch-
induced changes in alveolar epithelial cell marker expression. Together these data provide further
evidence that mechanical stimulation of the cytoskeleton and Rho activation are key upstream
events in mechanotransduction-associated alveolar epithelial cell differentiation.
Introduction
The alveolar epithelium is composed of two cell types: type II and type I cells (1). Type II
cells are responsible for surfactant production and play a role in lung host defense. Type I
cells, while less numerous, cover the majority of the gas exchange surface area of the lung.
Development and maintenance of this mixed population of alveolar epithelial cells depends
on both the biochemical milieu of growth factors, hormones, and extracellular matrix, and
the interplay of physical forces mediated intrinsically by the cytoskeleton and extrinsically
by cell-cell and cell-matrix interactions.
Stretch plays a critical role in lung development (2). Static stretch provided by fetal lung
fluid provides a constant distending force of approximately 2.5 mmHg (3). Fetal breathing
movements provide intermittent cyclic stretch (4) resulting in 3 to 5% change in alveolar
surface area (3). By comparison, changes in surface area with tidal breathing in adults are
minimal (5), while expansion to total lung capacity changes surface area by 40–45% (6).
The importance of stretch as a mechanism for lung development has been shown in human
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pregnancy complicated by premature membrane rupture (7), in neonatal neuromuscular
disorders (8), and in animal models (9).
By extension, enhanced stretch, generally from tracheal obstruction, promotes lung growth
(10,11), providing the rationale for the use of tracheal occlusion to reverse pulmonary
hypoplasia in congenital diaphragmatic hernia. While tracheal occlusion increases lung
growth through the retention of fetal lung fluid, the effects of this supraphysiologic stretch
on differentiation of the alveolar epithelium are less clear (12). Animal studies suggest that
static stretch favors the formation of type I cells (13) while cyclic stretch favors type II cells
(14), but the mechanisms by which stretch is translated into molecular signals to modify
gene expression in the alveolar epithelium are poorly understood.
The Rho-GTPase family of small messengers is an attractive candidate for mediating
stretch-induced cell signaling, due to its tight coupling to the cytoskeleton. As the
cytoskeleton is a global receiver and transmitter of mechanical forces (15), Rho-GTP
activation could be an early, upstream intracellular event in response to stretch. Rho
GTPases have been implicated in lung branching morphogenesis (16), alveolar epithelial
permeability (17), migration (18), and recently, maturation of alveolar type 2 cells (19). We
now show, using a validated, equibiaxial stretch device and human fetal lung epithelial cells,
that changes in epithelial cell phenotype between type I and type II cells with static stretch
are associated with activation of the Rho GTPase pathway.
Methods
Reagents
Dexamethasone, isobutyl methylxanthine, and 8-bromo-cAMP were purchased from Sigma
Chemical Co. (St. Louis, MO). All other supplies were purchased from Fisher (Fair Lawn,
NJ), Pierce (Rockford, IL) or Invitrogen (Carlsbad, CA). Antisera included SP-B
(Chemicon, Temecula, CA), Pepsinogen C (Abcam, Cambridge, UK), Claudin 7 (Zymed,
South San Francisco, CA), Plasminogen Activator Inhibitor-1 (BD Transduction
Laboratories, Lexington, KY), Caveolin-1α (Santa Cruz Biotechnologies, Santa Cruz, CA),
and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Chemicon).
Cell Culture
Human fetal lungs from 14–18-wk therapeutic abortions were obtained from Advance
Bioscience Resources, Inc. (Alameda, CA) and used in protocols approved by the
Committee for Human Research at The Children’s Hospital of Philadelphia. A stable
population of alveolar type II cells (with an average 10% contaminating fibroblasts, <5%
endothelial cells, and no inflammatory cells) were prepared as described previously (20),
and plated at a density of 7 X 105 cells/cm2 on deformable Silastic membranes (Specialty
Manufacturing, Saginaw, MI) coated with 50 μg/ml of fibronectin (BD Biosciences,
Medford, MA) and mounted into custom-made wells. Waymouth’s media containing 10 nM
dexamethasone, 0.1 mM 8-bromo-cAMP, and 0.1 mM isobutyl methylxanthine (DCI) was
used to maintain the type II cell phenotype.
Equibiaxial Stretch
Cells on Silastic membranes were mounted onto individual cell-stretching devices capable
of applying static equibiaxial strain, as previously described (6). 72 h after plating, cells
were stretched continuously for 24 h at either 10% or 37% change in surface area. These
equibiaxial deformations correspond to static stretches in isolated rat lungs at 55 and 100%
of total lung capacity, respectively.
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Cell viability and apoptosis
Ethidium homodimer-1 and calcein AM were added to the wells to assess cell viability
(LIVE/DEAD, Molecular Probes, Eugene, OR). Apoptosis was assessed by immunoblotting
for activated caspase 3 (R and D Systems, Minneapolis, MN). Cells treated with 1μM
Staurosporine (Sigma) served as a positive control.
Western immunoblotting
Cells were harvested in lysis buffer (1% Triton X-100, 150 mM NaCl, 50mM Tris-HCl, 5
mM ethylenediamine tetraacetic acid, 5% glycerol, pH 8.0) with 1X Protease inhibitor
(Roche, Indianapolis, IN), and samples immunoblotted using NuPAGE Bis-Tris gels
(Invitrogen). Primary antibody concentrations were: SP-B 1:4000; PGC 1:5000; Claudin 7,
PAI-1, and Caveolin 1 at 1:1000; GAPDH at 1:20,000. Secondary antibodies conjugated to
Alexa Fluor 680 (Molecular Probes) or IRdye 800 (Rockland, Gilbertsville, PA) were used
at a dilution of 1:10,000. Membranes were analyzed using the Odyssey infrared imaging
system (Li-Cor, Lincoln, NE).
Real-time reverse transcriptase PCR (RT-PCR)
Total cellular RNA was isolated using RNA STAT-60 Reagent (Tel-Test, Friarswood, TX).
Purity was verified by the OD 260:280 ratio and integrity assessed using the Agilent 2100
bioanalyzer system (Agilent, Palo Alto, CA). Real-time RT-PCR assays using a singleplex
strategy were done using an ABI Prism 7900 system (ABI, Foster City, CA). Details of the
two-step protocol have been described previously (21). The primer/probe sets (listed on the
ABI website, http://www.allgenes.com) were: SP-B Hs00167036, PGC Hs00160052,
claudin 7 Hs00600772, PAI-1 Hs00167155, Cav-1 Hs00184697, and 18s Hs99999901_S1.
Standards for comparison of RT-PCR results were derived from RNA isolated from alveolar
type II cells cultured from human fetal lung or from banked frozen adult human lung tissue.
Immunofluorescence Imaging
Experimental membranes with adherent cells were mounted on glass slides using
Fluoromount™ (Sigma). Cells were fixed with 1% paraformaldehyde in PBS, and
immunostained with Claudin 7 antibody (1:100). Nuclei were counterstained with DAPI.
Fluorescence was examined at 20X with an Olympus IX81 microscope and Slidebook 4.2.0
digital microscopy software (Olympus, San Diego, CA).
Stress fiber analysis
Alexa Fluor 549 Phalloidin (Molecular Probes, Eugene, OR) was used to stain the actin
cytoskeleton at the end of the stretching period. Stress fibers were counted in 7 random high
power fields (60X) per treatment group using Image Pro-Plus software (Version 6.0,
MediaCybernetics Inc, Bethesda, MD) to determine mean stress fiber intensity per cell.
Rho inhibition
Y27632, a selective ROCK inhibitor (Tocris, Ellisville, MO) was added to cells at a
concentration of 20μM/mL, 1 h prior to stretch and maintained throughout the experiment.
Direct activation of Rho was assessed using the G-Lisa Rho A Activation Assay
(Cytoskeleton, Denver, CO), which measures activated Rho-GTP, per the manufacturer’s
instructions.
Statistical Analysis
Results are expressed as mean ± standard error. Analysis of variance (for LIVE/DEAD) and
t-tests (all other experiments) were performed with GraphPad Prism 5.0 for Macintosh
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(GraphPad, San Diego, CA). All protein and RNA studies were normalized with GAPDH
and 18S, respectively.
Results
Static stretch modified alveolar epithelial cell phenotype without cell toxicity
Random field counting (n=4 experiments) revealed no changes in cell viability due to
culture or stretch (before stretch 92.8 ± 2.6% live cells; no stretch 24h 91.6 ± 1.2%; 10%
stretch 24h 94.0 ± 1.1%; 37% stretch 24h 93.8 ± 2.4%; p>0.05), and there was no evidence
of apoptosis after static stretch (Figure 1). RT-PCR revealed decreased expression of the
type II cell markers SP-B and PGC (Figure 2A) at 10% (SP-B: 61 ± 8% and PGC: 50 ± 5%
of unstretched control) and 37% change in surface area (SP-B: 50 ± 5% and PGC: 51 ± 7%;
n=5–7, p<0.01). These changes were not evident at the protein level (Figures 2B and C).
Induction of RNA for the type I cell markers Claudin 7 and PAI-1 (Figure 3A) occurred at
both 10% (Claudin 7: 1.5 ± .09-fold and PAI-1: 2.0 ± .04-fold vs. unstretched) and 37%
change in surface area (Claudin 7: 1.8 ± 0.1-fold and PAI-1: 3.4 ± 0.4-fold; n=3, p<0.05).
There was a modest induction of Caveolin-1 RNA with 10% stretch that did not reach
statistical significance (n=3, p=0.08). Immunoblotting demonstrated induction of PAI-1 and
Caveolin-1 protein with 37% stretch (Figures 3B and C; n=4–5, p<0.05), and a modest
increase in Claudin 7 protein expression with 10% stretch. We characterized Claudin 7
localization to the plasma membrane as a proxy for alveolar epithelial barrier changes since
the silastic membranes precluded traditional permeability testing. Claudin 7 was distributed
throughout the cytoplasm prior to stretch (Figure 4A) and in unstretched cells (not shown).
With static stretch (Figures 4B and C), Claudin 7 immunostaining was more prominent at
the plasma membrane.
Rho-GTP function in response to static stretch
Stress fibers are longitudinal bundles of contractile actin-myosin filaments resulting from
activation of the Rho-GTP/Rho kinase pathway (23). Stress fibers (as shown in Figure 5A)
are present in most cultured cells, but are markedly increased by stretch (24). There was a
27% increase in the mean intensity of phalloidin-positive stress fibers per cell at 37% stretch
compared to unstretched controls (Figure 5B; n=3, p<0.05), whereas no significant change
was observed at 10% stretch. Because stress fibers are a late endpoint in Rho pathway
activation, we measured direct Rho/Rho kinase pathway activation by ELISA in response to
37% stretch (Figure 6). Activated Rho-GTP increased by 21.4 ±1.5% 15 minutes after
initiation of 37% stretch (n=3–4, p<0.01), followed by a decrease at 1 and 4 h (at 4 h: 46.7 ±
5.4%, n=4, p<0.01), with variable rebound to baseline by 24 h.
Inhibition of Rho diminishes stretch phenotype changes
To determine whether the stretch induced changes in gene expression could be due to
activation of Rho, we used a selective Rho inhibitor, Y27632, during epithelial cell stretch
(Figure 7). Y27632 partially restored SP-B RNA expression at 10% stretch but not at 37%
stretch (n=4, p<0.05 vs. 10% stretch without inhibitor). By comparison, expression of
PAI-1 was blunted at both 10% and 37% stretch in the presence of Y27632 (n=4–5, p<0.05
vs. no inhibitor).
Discussion
Mechanical forces are important regulators of organogenesis and differentiation during fetal
development. Although reduced stretch results in lung hypoplasia while overdistention
stimulates lung growth (3), the effects of stretch on differentiation have been less clear.
Animal models suggest that static stretch promotes type I cell phenotype (13), and cyclic
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stretch promotes type II cell phenotype (25). More recent studies of animal models of
congenital diaphragmatic hernia (CDH) and post-mortem human studies suggest that despite
improved lung growth, supraphysiologic stretch in utero does not result in a mature alveolar
epithelium with an appropriate mixed population of type I and type II cells (26,27). This is
the first study to assess the impact of supraphysiologic stretch on alveolar epithelial cell
differentiation using a well-characterized model of type II cells derived from human fetal
lung in which both the local effects of static stretch and alterations in intracellular pathways
can be easily monitored.
Mechanistic studies of stretch-induced epithelial differentiation have been hampered by
controversy surrounding alveolar epithelial cell lineage and alveolar epithelial marker
expression. The classic dogma—alveolar type II cells as the progenitor for terminally
differentiated alveolar type I cells—came from interpretations of older studies using electron
microscopy to understand the resolution of lung injury (28). These early studies were
supported by later evidence that type II cells served as progenitors for injured type I cells in
mature lung (29), and that isolated type II cells in culture for over 24 h to lose characteristics
of type II cells and adopt features of type I cells in the absence of serum (30). Another
obstacle to understanding the impact of stretch on differentiation is the paucity of markers
that clearly differentiate type I from type II cells across species. Markers such as T1α (31)
and RTI40 (32), now recognized as podoplanin, have not been useful in human lung.
Markers that clearly distinguish type I cells from type II cells, such as Caveolin 1, are also
found in other cells locally in the lung (33). Antibodies to markers in rodent models have
poor cross-reactivity to human cells. The present study attempts to solve these problems by
using a relevant human model and choosing markers that have been reproducible in this and
other human models. Our well-characterized cell culture model has been used to examine
the cell biology and biochemistry of alveolar type 1 and 2 cells (20,34–36). Cells are derived
from human fetal lung making this model particularly relevant to lung development. The
primary cultures have been consistently ~90% pure, with contamination chiefly from
fibroblasts. However, the use of a human cell culture model restricts the choice of available
type I cell markers. We have previously shown that PAI-1, Caveolin 1, and Claudin 7 are
robust, reproducible markers of type I cells in this system (35). While not exclusively
expressed by type I cells in the lung, they are clearly not expressed by human type 2 cells or
by contaminating fibroblasts. Therefore, our choice of cell culture system and markers
provide a robust model to study the effects of stretch on human fetal alveolar epithelial cell
phenotype.
Equibiaxial stretch of type II cells had very predictable effects on the epithelial cell markers.
We demonstrated a decline in SP-B and PGC RNA within 24 h of initiating both 10% and
37% stretch, concomitant with an increase in PAI-1 and Caveolin 1 RNA. Compared to our
prior report of epithelial cell marker expression in transdifferentiation experiments (35), the
decline in type II cell markers with stretch despite the presence of hormones was blunted yet
significant. In the prior study, DCI withdrawal effectively eliminated SP-B and PGC RNA
expression by 96h, with persistence of some SP-B protein through 120h and PGC protein
through 96h. Persistence of type II cell proteins after cessation of RNA expression has been
commonly reported in rodent models of alveolar epithelial cell transdifferentiation (37,38).
Importantly, despite culture conditions that should sustain type II cell marker expression,
specifically the presence of glucocorticoid and cAMP, stretch significantly impaired SP-B
and PGC expression.
Few studies of the effects of stretch on alveolar epithelial cell differentiation have examined
type I cell markers (32). In the present study, type I cell markers behaved as predicted,
increasing in response to 24h of static stretch as type II marker expression waned. The
magnitude of changes in type I markers was less than we observed by transdifferentiation
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previously. Claudin 7 was helpful in the present study because of its type I cell specificity
specific in human fetal lung (34,35), and its role in alveolar epithelial barrier function (22).
While Claudin 7 behaved similarly to our prior study, demonstrating only a modest
induction of RNA and no significant change in protein content over 24h, it was remarkable
that localization of Claudin 7 became directed to the plasma membrane with stretch. Studies
of rat type I cell transdifferentiation also observed an increase in Claudin 7 that was
maximal after 7d in culture, with a more plasma membrane distribution in type I cells that
correlated with increased barrier function (39). The silastic membranes we used for the static
stretch in our system precluded a more functional approach to assessing barrier function.
However, redistribution of Claudin 7 is indirect but consistent evidence of enhanced barrier
function with stretch. Taken together, changes in type I and II cell marker expression clearly
show that despite culture conditions that support maintenance of type II cell phenotype,
stretch fosters change toward a type I cell phenotype in human fetal lung epithelial cells.
Several signal transduction pathways have been implicated in stretch-mediated lung
maturation, including extracellular signal related kinases (25), Protein Kinase A and C (2),
heparin-binding epidermal growth-like factor and transforming growth factor alpha (40).
The Rho/Rho kinase (ROCK) pathway is an excellent candidate for transmitting alveolar
epithelial cell stretch into gene expression due to its pivotal role in regulating the actin
cytoskeleton, and in mechanotransduction-mediated differentiation, most notably in smooth
muscle cells (41). We provide compelling evidence that Rho pathway activation plays an
important role in static stretch-induced differentiation of human fetal lung epithelium:
indirectly by the increase in stress fibers with static stretch, and directly by detecting GTP-
bound Rho within 15 minutes of applying static stretch. More importantly, stretch-induced
changes in epithelial cell marker expression were blunted in the presence of a specific Rho
inhibitor, Y27632. Our data echo similar observations in rodent type II cells, with the ROCK
inhibitor H-1152 blunting the effect of cyclic stretch on expression of the type II cell marker
SP-C (19). Like their studies, our data show that Rho A is a negative regulator of type II cell
markers, especially at reduced levels of stretch—5% in their study, and 10% in ours. What is
more impressive is that Rho A is a positive regulator of type I cell markers at both levels of
stretch in the present study, placing the Rho pathway as a central regulator of alveolar
epithelial differentiation in response to stretch. The differences in response between type I
and type II markers, and between 10% and 37% stretch may reflect events downstream of
Rho A. Y27632 is a ROCK inhibitor which will account for only one limb of the pathway
after Rho A activation leading to inhibition of cofilin and promoting actin polymerization
(24). Because an intact cytoskeleton is a critical factor in mediating mechanotransduction,
the role of profilin actions could be important but are not regulated by ROCK and thus not
susceptible to Y27632. The inability of ROCK inhibition to restore type 2 cell marker
expression to unstretched levels illustrates that there are additional mechanotransduction
pathways involved, such as the mitogen-activated protein kinase pathway (25). The resultant
intermediate type I/II cell phenotype may simply reflect the short duration of these
experiments. However, they suggest a reasonable explanation for the presence of such
intermediate cells observed by others in response to lung injury as repopulating type 2 cells
begin to transdifferentiate (27,42,43). While there is increasing evidence of type I to type II
cell plasticity (44), it remains unclear whether this is stretch-responsive in vivo and which
pathways might be involved.
In summary, we have shown that static stretch is an important determinant of alveolar
epithelial cell plasticity, and that mechanotransduction is partially mediated by the Rho
pathway. The Rho GTPase pathway may provide an important early indicator of alveolar
epithelial cell well-being in studies designed to evaluate lung-protective ventilation
strategies, and may offer a targeted pathway for the design of novel pharmacologic
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interventions, due to the accessibility of the alveolar epithelium, to prevent lung injury
during mechanical ventilation.
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Figure 1. Apoptosis during static stretch
Representative immunoblot for activated caspase 3 in type II cells after 24 h of no stretch
(NS), 10% or 37% stretch. Staurosporine-treated type II cells served as a positive control.
Equal loading was confirmed with GAPDH.
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Figure 2. Alveolar type II cell markers during with static stretch
(A) Graphic representation of real time RT-PCR results from 5–7 experiments for SP-B
(open bars) and PGC (shaded bars) mRNA at 10% and 37% static stretch for 24 h,
normalized to 18S rRNA (*p<0.01 vs. no stretch). (B) Immunoblot densitometry,
normalized to GAPDH, and (C) representative immunoblot.
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Figure 3. Alveolar type I cell markers during with static stretch
(A) Graphic representation of real time RT-PCR results from 3–4 experiments for Claudin 7
(open bars), PAI-1 (light bars), and Caveolin-1 (dark bars) at both 10 and 37% stretch for
24h, normalized to 18S rRNA (*p<0.05 vs. no stretch). (B) Immunoblot densitometry,
normalized to GAPDH (*p<0.05 vs. no stretch), and (C) representative immunoblot.
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Figure 4. Claudin 7 localization in response to static stretch
Representative images were taken at 60X of Claudin 7 immunostaining (red; DAPI staining
of nuclei, blue) in cells after 24 h of no stretch (A), 10% (B), or 37% (C) stretch. Plasma
membrane distribution of Claudin 7 is shown (arrowheads; n=2 experiments, duplicate
slides, 4 fields each).
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Figure 5. Stress fiber formation in response to static stretch
(A) Representative image taken at 20X of cells after 24 h of 37% stretch. Phalloidin-stained
stress fibers are red, DAPI-stained nuclei are blue. Image analysis software markings on
counted cells appear in yellow, and the black line (cell 15) illustrates a representative stress
fiber fluorescent signal density measurement. (B) Graphic representation of mean
fluorescent stress fiber intensity per cell (n=3 experiments, *p<0.05 vs. NS, **p<0.05 vs.
10%).
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Figure 6. Rho activation in response to static stretch
Time course of Rho-GTP by G-Lisa after initiation of 37% static stretch (n= 3–4
experiments, *p<0.01).
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Figure 7. Alveolar epithelial marker expression in response to ROCK inhibition during stretch
Graphic representation of real time RT-PCR results from 4–5 experiments for (A) SP-B and
(B) PAI1 mRNA after 24h of 37% static stretch in the presence or absence of the ROCK
inhibitor Y27632, normalized to 18S rRNA (*p<0.05). Cells were pre-treated with Y27632
for 1 h prior to initiating stretch.
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